In our chordoma PDX panel, homozygous loss of CDKN2A/2B was reported in 53.8% of the xenografts, followed by mutations affecting the SWI/SNF complexes (33.3%), representing most of genetic alterations found in chordomas [6,7]. Here, SMARCA1 is linked to chordoma.